Marc H M Thelen (Marc Thelen)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Chronic Kidney Disease

Clinical Evaluation

Top Venues

Clinical chemistry and laboratory medicine

Advances in laboratory medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marith van Schrojenstein Lantman, Remco Grobben, Antonius E van Herwaarden, Miranda van Berkel, Jeroen Schaap, Marc H M Thelen
To rule-in, or not to falsely rule-out, that is the question: evaluation of hs-cTnT EQA performance in light of the ESC-2020 guideline. Clinical chemistry and laboratory medicine 62 (6) (2024)
Pika Meško Brguljan, Marc H M Thelen, Francisco A Bernabeu-Andreu, Christos Kroupis, Guilaine Boursier, Ines Vukasović, Edward Barrett, Duilio Brugnoni, Maria Lohmander, Luděk Šprongl, Tatjana Vodnik, Irina Ghiţă, Florent J L A Vanstapel, Michel Vaubourdolle, Willem Huisman
EFLM Working Group Accreditation and ISO/CEN standards on dealing with ISO 15189 demands for retention of documents and examination objects. Advances in laboratory medicine 5 (2) (2024)
Josiane Arnaud, Cas Weykamp, Ross Wenzel, Marina Patriarca, Montserrat González-Estecha, Liesbeth Janssen, Ma'atem Beatrice Fofou-Caillierez, Montserrat Ventura Alemany, Valeria Patriarca, Irene de Graaf, Renaud Persoons, Mariona Panadès, Bernard China, Marieke Te Winkel, Hans van der Vuurst, Marc H M Thelen
Analytical performance specifications for trace elements in biological fluids derived from six countries federated external quality assessment schemes over 10 years. Clinical chemistry and laboratory medicine (2024)
Marc H M Thelen, Marith van Schrojenstein Lantman
When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias. Clinical chemistry and laboratory medicine 62 (8) (2024)
Marc H M Thelen, Marith van Schrojenstein Lantman
When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias. Clinical chemistry and laboratory medicine 62 (8) (2024)
Pika Meško Brguljan, Marc H M Thelen, Francisco A Bernabeu-Andreu, Christos Kroupis, Guilaine Boursier, Ines Vukasović, Edward Barrett, Duilio Brugnoni, Maria Lohmander, Luděk Šprongl, Tatjana Vodnik, Irina Ghiţă, Florent J L A Vanstapel, Michel Vaubourdolle, Willem Huisman
Advances in laboratory medicine 5 (2) (2024)
Marith van Schrojenstein Lantman, Remco Grobben, Antonius E van Herwaarden, Miranda van Berkel, Jeroen Schaap, Marc H M Thelen
To rule-in, or not to falsely rule-out, that is the question: evaluation of hs-cTnT EQA performance in light of the ESC-2020 guideline. Clinical chemistry and laboratory medicine (2024)
Huub H Van Rossum, Stefan Holdenrieder, Yeo-Min Yun, Dina Patel, Marc H M Thelen, Junghan Song, Nick Unsworth, Katherine Partridge, Melanie Moore, Wei Cui, Lakshmi Ramanathan, Qing H Meng, Bart E P B Ballieux, Catharine Sturgeon, Hubert Vesper
External quality assessment-based tumor marker harmonization simulation; insights in achievable harmonization for CA 15-3 and CEA. Clinical chemistry and laboratory medicine (2024)
Marith van Schrojenstein Lantman, Remco Grobben, Antonius E van Herwaarden, Miranda van Berkel, Jeroen Schaap, Marc H M Thelen
To rule-in, or not to falsely rule-out, that is the question: evaluation of hs-cTnT EQA performance in light of the ESC-2020 guideline. Clinical chemistry and laboratory medicine 62 (6) (2024)
Marc H M Thelen, Marith van Schrojenstein Lantman
When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias. Clinical chemistry and laboratory medicine (2024)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine 61 (4) (2023)
Marc H M Thelen, Marith van Schrojenstein Lantman, Guilaine Boursier, Florent J L A Vanstapel, Mauro Panteghini
In reply to: Limitations in using the EFLM WG-A/ISO approach for assessment of reagent lot variability. Clinical chemistry and laboratory medicine (2023)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine 61 (4) (2023)
Marith van Schrojenstein Lantman, Anne-Els van de Logt, Elma Prudon-Rosmulder, Marloes Langelaan, Ayşe Y Demir, Steef Kurstjens, Armando van der Horst, Aldy Kuypers, Aram Greuter, Jenny E Kootstra-Ros, Eline van der Hagen, Marlies Oostendorp, Roseri de Beer, Christian Ramakers, Dirk Bakkeren, Fokke Lindeboom, Dennis van de Wijngaart, Marc H M Thelen, Jack Wetzels, Miranda van Berkel
Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease. Clinical chemistry and laboratory medicine (2023)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine (2023)
Hikmet Can Cubukcu, Florent J L A Vanstapel, Marc H M Thelen, Marith van Schrojenstein Lantman, Francisco A Bernabeu-Andreu, Pika Meško Brguljan, Neda Milinkovic, Solveig Linko, Mauro Panteghini, Guilaine Boursier
APS calculator: a data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data. Clinical chemistry and laboratory medicine (2023)
Michiel Heron, Marco W J Schreurs, Inez-Anne Haagen, Bernard China, Ana Paula Faria, Anna-Riitta Vanhanen, Marc H M Thelen, Cas W Weykamp
Allergy: Evaluation of 16 years (2007-2022) results of the shared external quality assessment program in Belgium, Finland, Portugal and The Netherlands. Clinical chemistry and laboratory medicine (2023)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine 61 (4) (2023)
Luisa Martinez-Sanchez, Christa M Cobbaert, Raymond Noordam, Nannette Brouwer, Albert Blanco-Grau, Yolanda Villena-Ortiz, Marc H M Thelen, Roser Ferrer, Ernesto Casis, Francisco Rodríguez-Frias, Wendy P J den Elzen
Indirect determination of biochemistry reference intervals using outpatient data. PloS one 17 (5) (2022)
Roseri Roelofsen-de Beer, Jos Pm Wielders, Guilaine Boursier, Tatjana Vodnik, Florent J L A Vanstapel, Willem Huisman, Ines Vukasović, Michel Vaubourdolle, Cigdem Atay Sonmez, Solveig Linko, Duilio Brugnoni, Christos Kroupis, Maria Lohmander, Luděk Šprongl, Francisco A Bernabeu-Andreu, Pika Meško Brguljan, Marc H M Thelen
Validation and verification of examination procedures in medical laboratories: opinion of the EFLM Working Group Accreditation and ISO/CEN standards (WG-A/ISO) on dealing with ISO 15189:2012 demands for method verification and validation. Clinical chemistry and laboratory medicine 58 (3) (2021)
Marith van Schrojenstein Lantman, Marc H M Thelen
The impact of measurement uncertainty on the uncertainty of ordinal medical scores based on continuous quantitative laboratory results. Clinical chemistry and laboratory medicine 59 (8) (2021)
Marc H M Thelen, Florent J L A Vanstapel, Pika Meško Brguljan, Bernard Gouget, Guilaine Boursier, Edward Barrett, Christos Kroupis, Maria Lohmander, Luděk Šprongl, Tatjana Vodnik, Francisco A Bernabeu-Andreu, Ines Vukasović, Cigdem Atay Sonmez, Solveig Linko, Duilio Brugnoni, Michel Vaubourdolle, Willem Huisman, Roseri Roelofsen-de Beer, null null
Documenting metrological traceability as intended by ISO 15189:2012: A consensus statement about the practice of the implementation and auditing of this norm element. Clinical chemistry and laboratory medicine 57 (4) (2019)